Kevin McDaniel is an experienced professional in access and reimbursement within the healthcare industry, currently serving as the Associate Director of Access & Reimbursement for Oncology & Neurology at Eisai US since June 2023. Previously, McDaniel held senior positions related to market access and reimbursement in neurology at Biogen, where significant achievements included launching Spinraza in Michigan. Prior roles include serving as a Neuroscience Account Executive at AbbVie, where McDaniel was involved in launching Zinbryta, and a Professional Healthcare Representative at Pfizer, focusing on various therapeutic areas. McDaniel also has a considerable public service background, serving as Mayor and Councilman for the City of Auburn Hills, along with earlier roles in law enforcement. McDaniel holds a Bachelor of Science degree in Management Information Systems from Oakland University.
This person is not in any teams
This person is not in any offices